Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region
Background: Clinical remission is an attainable goal for Rheumatoid Arthritis (RA). However, data on RA remission rates from multinational studies in the Asia-Pacific region are limited. We conducted a cross-sectional multicentric study to evaluate the clinical remission status and the related facto...
Saved in:
Main Authors: | Xing Sun (Author), Ru Li (Author), Yueming Cai (Author), Adeeba Al-Herz (Author), Manjari Lahiri (Author), Minhaj Rahim Choudhury (Author), Rudy Hidayat (Author), Bagus Putu Putra Suryana (Author), Yuko Kaneko (Author), Keishi Fujio (Author), Nguyen Van Hung (Author), Sapan Pandya (Author), Leong Khai Pang (Author), Wanruchada Katchamart (Author), Keshav Raj Sigdel (Author), Buddhi Paudyal (Author), Pongthorn Narongroeknawin (Author), Parawee Chevaisrakul (Author), Feng Sun (Author), Yu Lu (Author), Carmen Ho (Author), Swan Sim Yeap (Author), Zhanguo Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
by: Juthamas Prawjaeng, et al.
Published: (2023) -
Significance of the multiomics approach to elucidate disease mechanisms in humans
by: Keishi Fujio
Published: (2022) -
Entering the era of precision medicine through multiomics approach
by: Keishi Fujio
Published: (2022) -
Multi-omics approach to precision medicine for immune-mediated diseases
by: Mineto Ota, et al.
Published: (2021) -
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
by: Hirofumi Shoda, et al.
Published: (2023)